They observed early-stage physiological disruptions in DA neurons derived from induced pluripotent stem cells (iPSCs) of patients carrying a mutation in the β-glucocerebrosidase (GCase) enzyme encoded by the GBA gene (GBA-N370S mutation), a prominent genetic risk factor for PD. The gene discussed is GBA1; the disease is Parkinson disease.